HOME NEWS EARNINGS RESULTS PICKS STRATEGY BLOG CONTACT SUBSCRIBE LOGIN SUBSCRIBE JOIN FREE
LOADING
Price Investing Group
← Back to Research Watchlist
LEGN
Legend Biotech Corp
Healthcare Biotechnology ADR · New Jersey, USA · Reports in usd
Market Cap: $5.20B
Market Cap
$5.20B
Enterprise Val
$4.76B
P/E Ratio
-20.78
P/B Ratio
5.37
Trailing PEG (1Y)
0.47
As Of
May 19, 2026

Overview & Key Metrics

Reporting period: Mar 31, 2026 · Q1 2026
Book Value$967.7M
Gross Margin42.35%
Profit Margin42.35%
Return on Equity-24.92%
Return on Assets-14.87%
Current Ratio2.13
Debt/Equity0.40
LT Debt/Equity0.12
Revenue Per Share1.65

Income Statement

Mar 31, 2026
Revenue$305.1M
Cost of Revenue$175.9M
Gross Profit$129.2M
R&D$85.7M
SG&A$90.1M
Operating Expenses$179.0M
Operating Income-$49.8M
Interest Expense$5.5M
Tax Expense$1.2M
Net Income-$54.3M
EPS (Basic)$-0.30
EPS (Diluted)$-0.30
EBIT-$47.6M
EBITDA-$32.0M
Consolidated Income-$54.3M
Non-Controlling Interests$0.00

Balance Sheet

Mar 31, 2026
Cash & Equivalents$834.6M
Accounts Receivable$1.7M
Inventory$37.1M
Current Assets$1.08B
LT Investments$0.00
Property, Plant & Equipment$452.5M
Intangibles$0.00
Non-Current Assets$514.0M
Total Assets$1.60B
Accounts Payable$204.5M
Current Debt$277.2M
Current Liabilities$509.1M
LT Debt$112.1M
Non-Current Liabilities$119.9M
Total Liabilities$629.0M
Total Debt$389.3M
Shareholder Equity$967.7M
Shares Outstanding369,886,369

Cash Flow Statement

Mar 31, 2026
Operating Cash Flow-$85.1M
Investing Cash Flow-$168.0M
Financing Cash Flow-$1.2M
CapEx-$7.5M
Free Cash Flow-$92.6M
Depreciation & Amort.$15.6M
Stock-Based Comp$19.3M
Acquisitions / Disposals-$18.4M
Investment Activity-$142.1M
Debt Issued/Repaid-$1.3M
Equity Issued/Repaid$100.0K
Net Change in Cash-$255.5M
Data cached · Meta cache · Daily cache · Statements cache · TTL 24h